A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : MAPKi

Search Conditions:
Search Keyword : MAPKi
Search Method : Exact match.
Research Area:

Abbreviation: MAPKi
Appearance Frequency: 35 time(s)
Long forms: 7

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
MAPK inhibitors
(15 times)
(9 times)
CPT1A (1 time)
CR (1 time)
EDN1 (1 time)
2014 Inter- and intra-patient heterogeneity of response and progression to targeted therapy in metastatic melanoma.
mitogen-activated protein kinase inhibitors
(12 times)
(9 times)
OS (4 times)
PFS (4 times)
DCR (2 times)
2016 Proteomics approaches to understanding mitogen-activated protein kinase inhibitor resistance in melanoma.
MAP kinase inhibitor
(2 times)
(1 time)
GO (1 time)
GSEA (1 time)
PFS (1 time)
2018 Proteomics-based insights into mitogen-activated protein kinase inhibitor resistance of cerebral melanoma metastases.
MAP-kinase pathway inhibitors
(2 times)
(2 times)
BM (1 time)
2015 Survival patterns following brain metastases for patients with melanoma in the MAP-kinase inhibitor era.
MAPK pathway inhibitor
(2 times)
(1 time)
BRAFi (1 time)
OXPHOS (1 time)
2015 Vemurafenib resistance reprograms melanoma cells towards glutamine dependence.
MAPK signaling inhibitors
(1 time)
(1 time)
IGF-1R (1 time)
2018 SIRT6 haploinsufficiency induces BRAFV600E melanoma cell resistance to MAPK inhibitors via IGF signalling.
MAPK signalling pathway inhibitors
(1 time)
Cell Biology
(1 time)
--- 2018 Melanoma cells resistant towards MAPK inhibitors exhibit reduced TAp73 expression mediating enhanced sensitivity to platinum-based drugs.